The Evolving Role of Cytokine Therapy for Renal Cell Carcinoma: Past, Present, and Future

Download All
Expert guidance for physicians, nurses, and pharmacists on evolving cytokine therapy for RCC.
Brendan D. Curti, MD

Clinicians Guide

Download this PDF for guidance on the safe and effective use of HD IL-2 for patients with renal cell carcinoma.

Brendan D. Curti, MD Released: November 11, 2020
Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Clinigen Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings